Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1979-05-10
1981-03-31
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
424272, A61K 3142, A61K 31425
Patent
active
042593425
ABSTRACT:
Antianginal pharmaceutical compositions containing as the active ingredient a compound of the formula ##STR1## wherein R.sub.1 is hydrogen, unsubstituted or hydroxyl-substituted alkyl of 1 to 4 carbon atoms; allyl; or unsubstituted or halo-, methyl-, methoxy- or trifluoromethyl-substituted benzyl; and
REFERENCES:
patent: 3804849 (1974-04-01), Griss et al.
patent: 3907996 (1975-09-01), Griss et al.
Goodman et al.,The Pharmacological Basis of Therapeutics, The MacMillan Co., N.Y., 3rd Ed., 1965, pp. 563-565, 736-751.
The Merck Manual, Merck & Co., Rahway, N.J., 12th Ed., 1972, pp. 371-375.
Benedikter Lothar
Griss Gerhart
Ihrig Hanns
Kobinger Walter
Pichler Ludwig
Boehringer Ingelheim GmbH
Fagelson Anna P.
LandOfFree
Antianginal treatment with azepine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antianginal treatment with azepine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antianginal treatment with azepine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2243033